ArticlePloS one2013

Maraviroc, a CCR5 antagonist, prevents development of hepatocellular carcinoma in a mouse model.

Laura Ochoa-Callejero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.